Blog - Page 1509 of 5718

TuesdayFeb 16, 2021 2:28 pm

XPhyto Therapeutics Corp. (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT) Outlines 2021 Business Strategies for COVID-19 PCR Testing and Psychedelic Treatments

XPhyto Therapeutics Corp. plans to commercialize its rapid and portable PCR Kit this year to provide point-of-care diagnostics The company is confident about the successful validation of the PCR kit for the European commercial (CE-IVD) approval in Q1 2021 Hugh Rogers, CEO and Director of XPhyto, revealed in the latest news release that the company will make investments and development of psychedelic treatments XPhyto Therapeutics Corp. (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT) is a bioscience accelerator involved in the development of new pharmaceuticals, diagnostic products, and psychedelic medicine. As a part of its business strategy for the year 2021, the company…

TuesdayFeb 16, 2021 2:13 pm

Pure Extracts Technologies (CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ) Delineates Parameters and Timeline of Study into Psilocybin-Based Active Treatments

Pure Extract Technologies pursues study into psilocybin active treatments Study to extend for 250-day period, targeting a number of milestones The study is set to be carried out at Toronto Institute of Pharmaceutical Technology, will be supervised by Pure Extracts’ scientific advisor, Dr. Alexander MacGregor Oregon recently voted to legalize psilocybin mushrooms for therapeutic use, a potential legislative movement which may soon be replicated in other jurisdictions Pure Extracts Technologies (CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ), a plant-based extraction company focused on the cannabis, hemp, and functional mushroom sectors, has provided investors with an update in regards to its ongoing…

TuesdayFeb 16, 2021 2:02 pm

QualityStocksNewsBreaks – Artelo Biosciences Inc. (NASDAQ: ARTL) Appoints Senior Pharmaceutical Exec as New SVP, Chief Scientific Officer

Artelo Biosciences (NASDAQ: ARTL), a clinical stage biopharmaceutical company focused on the development of therapeutics that modulate endogenous signaling pathways including the endocannabinoid system, today announced the appointment of Andrew Yates, Ph.D, as senior vice president and chief scientific officer. Dr. Yates is an experienced senior pharmaceutical executive, having most recently served at AstraZeneca in significant roles across a number of functional areas including development and commercial strategy, medical affairs and business development. Notably, Dr. Yates has been extensively involved in the life-cycle management of key multi-billion-dollar products including CRESTOR(R), FORXIGA(R) and KEYTRUDA(R). “We are extremely pleased to announce the…

TuesdayFeb 16, 2021 1:22 pm

QualityStocksNewsBreaks – Spectrum Global Solutions Inc. (SGSI) Announces $2.8M Contract Awarded to High Wire Networks

Spectrum Global Solutions (OTCQB: SGSI) has announced that High Wire Networks Inc. was awarded a $2.8 million electrical contract to provide power and fire-alarm infrastructure for new 150,000-square-foot distribution center near Chicago. SGSI previously announced that it had entered into a definitive agreement for a merger with High Wire; the merger, which is anticipated to close within the next few weeks, is subject to specified closing conditions. The multimillion-dollar contract calls for the installation of a 2,500 amps electrical service and infrastructure to power multiple robotic charging stations as well as a large conveyance system at the distribution center, which…

TuesdayFeb 16, 2021 1:12 pm

QualityStocksNewsBreaks – Hollywall Entertainment Inc. (HWAL) Selects IBN as Official Corporate Communications Partner

Hollywall Entertainment (OTC: HWAL), a telecommunications, media, technology, broadcasting and entertainment company, announced that it has chosen InvestorBrandNetwork (“IBN”), a multifaceted financial news and publishing company, to provide its corporate communications. The announcement noted that as part of the partnership, IBN will distribute Hollywall news and communications throughout its comprehensive distribution network of 5,000-plus syndication outlets; IBN will also leverage is wide range of newsletters, social media channels, blogs, and wire services to build and strengthen awareness for Hollywall. Hollywall’s portfolio spans a wide range of industries, including infrastructure development, 5G and telecommunications, broadcasting, education, media and entertainment. Through its development company, Hollywall…

TuesdayFeb 16, 2021 12:59 pm

QualityStocksNewsBreaks – Hunter Technology Corp. (TSXV: HOC) (OTCQB: HOILF) (WKN: A2QEYH) (FSE: RWPM) to Launch Pilot Service Utilizing Blockchain-Based Platform

Hunter Technology (TSXV: HOC) (OTCQB: HOILF) (WKN: A2QEYH) (FSE: RWPM) on Monday announced that it is on track to launch a pilot service for selected customers, including governments, sovereign wealth funds, environmental agencies, regulators and self-regulatory organizations ("users"), in the third quarter of 2021. Per the update, the company is developing its end-to-end service utilizing a proprietary blockchain-based modular software platform to supply users with immutable data intelligence on the full lifecycle of the crude oil supply chain from reserve management through wellhead production, storage, transhipment, export and/or domestic consumption. "Hunter with its technology platform and integration capabilities will support…

TuesdayFeb 16, 2021 12:48 pm

SRAX Inc. (NASDAQ: SRAX) Sequire Platform Provides Exclusive Access to B. Riley Vision Day Content; Company Announces Closing on BIGtoken Transaction

As host to B. Riley’s Securities’ 2021 Vision Day, SRAX offers event content to Sequire community SRAX CEO states that B. Riley event is “perfect example of our growing Virtual Event Platform capabilities” Definitive agreement between SRAX-created BIGtoken, FPVD closes SRAX (NASDAQ: SRAX), a financial technology company that unlocks data and insights for publicly traded companies through Sequire, its SaaS platform, concluded its role as the exclusive technology host for B. Riley Securities’ 2021 Vision Day (https://ibn.fm/D7R3c); sessions from the event are available exclusively to B. Riley clients and investors on the Sequire platform. The company also announced that its BIGtoken platform…

TuesdayFeb 16, 2021 12:06 pm

QualityStocksNewsBreaks – Pure Extracts Technologies Corp. (CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ) Enters Licensing Deal with Taste-T LLC

Pure Extracts Technologies (CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ), a plant-based extraction company focused on cannabis, hemp and the rapidly emerging functional mushroom sector, has announced its licensing deal with U.S. based Taste-T LLC. According to the update, Taste-T utilizes a proprietary manufacturing system to produce and package branded cannabis gummies and sells them in multiple U.S. states including Nevada, Massachusetts, Michigan and Oklahoma. Their famous products come in unique blister packaging and include Margarita Chill and Fireball Cinnamon. Pure Extracts has signed an agreement with exclusive rights for Canada and first rights to other countries around the world. Included…

TuesdayFeb 16, 2021 11:51 am

QualityStocksNewsBreaks – Plus Products Inc. (CSE: PLUS) (OTCQX: PLPRF) Announces Strategic Expansion of Sales Force

Plus Products (CSE: PLUS) (OTCQX: PLPRF), a cannabis and hemp branded products company in the U.S., today announced a strategic shift to expand its sales team, internalize all account management and transition to a self-service distribution partner in the California adult-use market. To date, PLUS has partnered with full-service distributors, relying on a hybrid of both internal and external personnel to make up its sales force. Under the new self-service model, a member of the PLUS team will own the sales cycle for every order start to finish. “At PLUS, we are focused on bringing customers the best possible experience…

TuesdayFeb 16, 2021 11:36 am

MustGrow Biologics Corp. (CSE: MGRO) (OTCQX: MGROF) (FRA: 0C0) Plant-Based Biopesticide Achieves 100% Control of Root-Rot Disease in Recent Studies

Most recent tests show MustGrow’s patented biopesticide achieved 100% control over Aphanomyces within 24 hours Plant-based biopesticide uses natural defense mechanism found in mustard seed to control diseases, pests and weeds MustGrow hoping to provide valuable crop-protection tool for pulse-crop farmers MustGrow Biologics (CSE: MGRO) (OTCQX: MGROF) (FRA: 0C0) has announced that its plant-based biopesticide has achieved 100% control of root-rot disease in a recent round of laboratory tests (https://ibn.fm/WJo4p). MustGrow, an agriculture biotech company focused on providing natural science-based biological solutions for high-value crops such as fruits and vegetables, is focused on providing natural, science-based biological solutions to replace synthetic…

Site Search

Company Search